TailAdmin is a free and open-source admin dashboard template built on React and Tailwind CSS, providing developers with everything they need to create a comprehensive, data-driven back-end, dashboard, ...

We are committed to delivering exceptional service and superior investment results." The Portfolio Solutions Group is a comprehensive multi-asset business, with activity across all asset strategies ...

Global financial markets are witnessing a historic breakdown in traditional relationships among key asset classes such as gold, currencies, bond yields, and real interest rates, according to Quant ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

The below dashboard compares White House, House, and Senate spending proposals for science and technology programs in FY 2026. It will be updated regularly as the funding debate unfold. Click on ...

Against the heightened volatility of asset prices, Chapter 1 assesses that global financial stability risks have increased significantly. This assessment is supported by three key forward-looking ...

Jio BlackRock Asset Management Private Ltd (JioBlackRock Asset Management), a 50:50 joint venture between Jio Financial Services Ltd (JFSL) and BlackRock, has received regulatory approval from the ...

JioBlackRock Asset Management also announced the appointment of Sid Swaminathan as it’s Managing Director and Chief Executive Officer (CEO). (Photo: Courtesy BSE twitter) Jio BlackRock Asset ...

BELLEVUE, Wash. & SYDNEY, May 27, 2025--(BUSINESS WIRE)--Smartsheet, the AI-powered, enterprise-grade work management platform, today unveiled Smartsheet Regions Australia, a new data residency ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We’ve tested more than 30 dash cams in real driving conditions. Thanks to that in-depth ...

The Big Pharma has penned a deal to acquire SiteOne Therapeutics, primarily for a non-opioid pain asset ready to enter phase 2 trials. Collectively, SiteOne shareholders could receive as much as $ ...